BioCryst Pharmaceuticals, Inc.BCRX
Close of Friday, October 23, 2026 · BioCryst Pharmaceuticals, Inc. is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$7.65
vs its Pivot
-12.2%
OnlyAlpha Score
41
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -10.2% | -1.9% | +8.1% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
IBB · 0.13%IWM · 0.06%
Big investors that own it (latest 13F)
| Perceptive Advisors | 1.6% of holdings |
| RA Capital | 1.4% of holdings |
| OrbiMed | 0.3% of holdings |
Get BCRX in your free daily emailAfter every close: whether BCRX is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track BCRX free → Full Stock check
Track BCRX free → Full Stock check